RS-102221
id:
rs-102221-256-1479669
title:
RS-102221
text:
RS-102221 is a drug developed by Hoffmann–La Roche, which was one of the first compounds discovered that acts as a potent and selective antagonist at the serotonin 5-HT2C receptor, with around 100× selectivity over the closely related 5-HT2A and 5-HT2B receptors. It has anxiolytic effects in animal studies, increases the effectiveness of SSRI antidepressants, and shows a complex interaction with cocaine, increasing some effects but decreasing others, reflecting a role for the 5-HT2C receptor in
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/RS-102221
date created:
date modified:
2024-04-05T20:48:03Z
main entity:
{"identifier":"Q7277678","url":"https://www.wikidata.org/entity/Q7277678"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/a/a5/RS-102221.svg","width":200,"height":144}
fields total:
13
integrity:
15